Natrol

Glucosamine, Chondroitin & MSM

C-
N+ Score67
Joint & BoneServing: 1 Tablet(s)Type: Other Combinations

Natrol Glucosamine, Chondroitin & MSM is a joint and bone support supplement containing four ingredients. Each tablet provides 500mg of Glucosamine Hydrochloride, 350mg of Chondroitin Sulfate, and 83mg of Methylsulfonylmethane (MSM), alongside 28mg of Sodium. Research suggests that Glucosamine and Chondroitin are commonly used for joint health, though the dosages in this product are below typically studied clinical amounts for these ingredients. The product received an N+ Score of 67, earning a C- grade, indicating it is an average-tier supplement based on its ingredient adequacy and formula completeness. With a total of four ingredients listed, the label transparency is 100%. This product may be suitable for individuals seeking basic joint support, but higher dosages of key ingredients might be more beneficial for some users.

About This Product

Glucosamine, Chondroitin & MSM by Natrol is a joint & bone supplement containing 4 active ingredients. It has earned an N+ Score of 67/100 (Grade C-).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness50/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity86/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms

Weaknesses

  • No major weaknesses identified

Ingredient Analysis (4 ingredients)

IngredientAmountDose Adequacy
Sodium28.000 mgN/A
Chondroitin Sulfate350.000 mgN/A
Methylsulfonylmethane83.000 mgN/A
Glucosamine Hydrochloride500.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.